Gaurav

Employment

• All India Institute of Medical Sciences Bhopal Associate Professor
  2023 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• A quasi-experimental study evaluating the efficacy of crossmatch-matched platelet transfusions in hemato-oncology patients with suspected alloimmune platelet refractoriness: A single-centre experience.
  Transfusion medicine (Oxford, England) 2026 DOI: 10.1111/tme.70058
  +Save
• Sickle Cell Trait – An Overlooked Cause of Altitude Associated Splenic Infarct: A Case Series
  Indian Journal of Hematology and Blood Transfusion 2026 DOI: 10.1007/s12288-025-02261-y
  +Save
• Efficacy of traditional medicine in the management of sickle cell disease: a scoping review of current evidence.
  Journal of complementary & integrative medicine 2025 DOI: 10.1515/jcim-2025-0238
  +Save
• Association of Markers of iron Metabolism with Mucormycosis: A Case Control Study.
  Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2025 DOI: 10.1007/s12070-025-05506-4
  +Save
• Myeloid sarcoma of the breast with synchronous early T‐cell precursor acute lymphoblastic leukemia: A rare presentation
  International Journal of Laboratory Hematology 2025 DOI: 10.1111/ijlh.14360
  +Save
• A Rare Case of Familial Methemoglobinemia with Congenital Heart Disease
  Oman Medical Journal 2024 DOI: 10.5001/OMJ.2024.16
  +Save
• A Single-Centre Experience of First-Line Romiplostim and Immunosuppressive Therapy in Patients With Aplastic Anemia
  Cureus 2023 DOI: 10.7759/CUREUS.37682
  +Save
• A case of intravascular large B-cell lymphoma – Our clinical experience
  Journal of Hematology and Allied Sciences 2023 DOI: 10.25259/JHAS_36_2022
  +Save
• B-lymphoblastic lymphoma presenting as acute pancreatitis: a rare mimicker
  Hematology, Transfusion and Cell Therapy 2023 DOI: 10.1016/J.HTCT.2021.02.004
  +Save
• PB1906: HYPOMETHYLATING AGENT PLUS LOW DOSE VENETOCLAX – A CHEMOTHERAPY-FREE INDUCTION OF ACUTE MYELOID LEUKEMIA TO ACHIEVE COMPLETE REMISSION IN PATIENTS UNFIT FOR CHEMOTHERAPY
  HemaSphere 2023 DOI: 10.1097/01.HS9.0000974448.45321.57
  +Save